Literature DB >> 32855511

New directions in necrotizing enterocolitis with early-stage investigators.

Troy A Markel1,2, Colin A Martin2,3, Hala Chaaban2,4, Jennifer Canvasser2, Heather Tanner2, Heather Denchik2, Misty Good5,6.   

Abstract

The 2019 Necrotizing Enterocolitis (NEC) Symposium expanded upon the NEC Society's goals of bringing stakeholders together to discuss cutting-edge science, potential therapeutics and preventative measures, as well as the patient-family perspectives of NEC. The Symposium facilitated discussions and shared knowledge with the overarching goal of creating "A World Without NEC." To accomplish this goal, new research to advance the state of the science is necessary. Over the last decade, several established investigators have significantly improved our understanding of the pathophysiology of NEC and they have paved the way for the next generation of clinician-scientists funded to perform NEC research. This article will serve to highlight the contributions of these young clinician-scientists that seek to elucidate how immune, microbial and nervous system dysregulation contributes to the pathophysiology of NEC.

Entities:  

Year:  2020        PMID: 32855511      PMCID: PMC7934965          DOI: 10.1038/s41390-020-1078-0

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  78 in total

1.  Prevention and early recognition of necrotizing enterocolitis: a tale of 2 tools--eNEC and GutCheckNEC.

Authors:  Sheila M Gephart; Christine Wetzel; Brittany Krisman
Journal:  Adv Neonatal Care       Date:  2014-06       Impact factor: 1.968

2.  The contributions of red blood cell transfusion and severe anemia in necrotizing enterocolitis: causes or confounders?

Authors:  D D Flannery; E E Foglia
Journal:  J Perinatol       Date:  2017-03-23       Impact factor: 2.521

3.  Age-dependent levels of plasma neuropeptides in normal children.

Authors:  M Sue O'Dorisio; Marsha Hauger; Thomas M O'Dorisio
Journal:  Regul Pept       Date:  2002-11-15

4.  Lysophosphatidylcholine alters enterocyte monolayer permeability via a protein kinase C/Ca2+ mechanism.

Authors:  Toshio Sawai; Robert Lampman; Yang Hua; Bradley Segura; Robert A Drongowski; Arnold G Coran; Caroll M Harmon
Journal:  Pediatr Surg Int       Date:  2002-09-19       Impact factor: 1.827

5.  Environmental-mediated intestinal homeostasis in neonatal mice.

Authors:  Courtney Culbreath; Scott M Tanner; Venkata A Yeramilli; Taylor F Berryhill; Robin G Lorenz; Colin A Martin
Journal:  J Surg Res       Date:  2015-04-10       Impact factor: 2.192

6.  Histones trigger sterile inflammation by activating the NLRP3 inflammasome.

Authors:  Ramanjaneyulu Allam; Murthy Narayana Darisipudi; Jurg Tschopp; Hans-Joachim Anders
Journal:  Eur J Immunol       Date:  2013-09-06       Impact factor: 5.532

7.  Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9.

Authors:  Misty Good; Chhinder P Sodhi; John A Ozolek; Rachael H Buck; Karen C Goehring; Debra L Thomas; Amit Vikram; Kyle Bibby; Michael J Morowitz; Brian Firek; Peng Lu; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

Review 8.  The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function.

Authors:  Christian Sina; Claudia Kemper; Stefanie Derer
Journal:  Semin Immunol       Date:  2018-02-24       Impact factor: 11.130

9.  The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide.

Authors:  Zaid Altaany; YoungJun Ju; Guangdong Yang; Rui Wang
Journal:  Sci Signal       Date:  2014-09-09       Impact factor: 8.192

10.  Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy.

Authors:  Yu Zhou; Jixin Yang; Daniel J Watkins; Laura A Boomer; Mika A Matthews; Yanwei Su; Gail E Besner
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.